Latest News

Date Title Topic
06 Mar 2017 The Polish Translation of our ESMO Patient Guide in Cervical Cancer is Now Available Online
06 Mar 2017 NICE Issues a Quality Standard in Diagnosis, Assessment and Management of Head and Neck Cancer Head and neck cancers
03 Mar 2017 EMA Recommends Granting a Marketing Authorisation for Pemetrexed Hospira UK Limited Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 Mar 2017 Press Release: Save the Dates for Upcoming ESMO Meetings
02 Mar 2017 EMA Recommends Granting a Marketing Authorisation for Rolapitant Palliative and supportive care
01 Mar 2017 Association Between Gut Microbiome and Responses to Anti-PD-1 Therapy in Patients with Metastatic Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
28 Feb 2017 EMA Recommends Extensions of Indication for Daratumumab Haematologic malignancies - Anticancer agents & Biologic therapy
27 Feb 2017 EMA Recommends Extensions of Indications for Dabrafenib and Trametinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 Feb 2017 Polish Translations of ESMO Patient Guides in Bone Sarcoma, Glioma, Liver Cancer and Ovarian Cancer are Now Online
24 Feb 2017 FDA Approves Lenalidomide as Maintenance Therapy for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Haematologic malignancies - Anticancer agents & Biologic therapy
23 Feb 2017 NICE Issues Diagnostics Guidance on Molecular Testing Strategies for Lynch Syndrome in Patients with Colorectal Cancer Pathology/Molecular biology - Gastrointestinal cancers
22 Feb 2017 First Comprehensive Paediatric Haematology-Oncology Initiative Launched in Africa Bioethics, legal and economic issues - Cancer in Special Situations - Haematologic malignancies
22 Feb 2017 Annals of Oncology Press Release: Death Rates from Cancer will Fall Faster in Men than in Women in Europe in 2017
21 Feb 2017 Phase II Study Supports Potential for Atezolizumab plus Bevacizumab for Locally Advanced or Metastatic Renal Cell Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
20 Feb 2017 FDA Accepts Two sBLAs for Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer in Cisplatin-Ineligible First-Line and Second-Line Post-Platinum Failure Treatment Settings Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy